Dr. Eriksson is a strategy, operations and board advisor working with some of the most innovative companies in Life Sciences. He is the former CEO and current Strategic Advisor at Trialbee, a leader in the digitization of clinical research whose clinical trial patient recruitment & enrollment platform is used across the industry in global clinical trials to help biopharmaceutical and medical device companies meet enrollment timelines. An executive with extensive experience in clinical drug development at the clinic, sponsor and CRO levels including Merck & Co. Inc., PAREXEL and ICON. Dr. Eriksson is trained and skilled in clinical pharmacology, clinical research, clinical research operations with emphasis on health care alliances, site operations, feasibility, study start-up & implementation and patient recruitment. He is a strong business development and leadership professional with an innovative and creative mind to address clinical development challenges and realize new opportunities. Dr. Eriksson is an Associate Professor in Clinical Pharmacology at Lund University, Sweden and at Rutgers University School of Health-Related Professionals in New Jersey, USA.